Mammalian G-protein-coupled receptor expression in Escherichia coli: I. High-throughput large-scale production as inclusion bodies.

G-protein-coupled receptors (GPCRs) represent approximately 3% of human proteome and the most prominent class of pharmacological targets. Despite their important role in many functions, only the X-ray structures of rhodopsin, and more recently of the beta(1)- and beta(2)-adrenergic receptors, have been resolved. Structural studies of GPCRs require that several tedious preliminary steps be fulfilled before setting up the first crystallization experiments: protein expression, detergent solubilization, purification, and stabilization. Here we report on screening expression conditions of approximately 100 GPCRs in Escherichia coli with a view to obtain large amounts of inclusion bodies, a prerequisite to the subsequent refolding step. A set of optimal conditions, including appropriate vectors (Gateway pDEST17oi), strain (C43), and fermentation at high optical density, define the best first instance choice. Beyond this minimal setting, however, the rate of success increases significantly with the number of conditions tested. In contrast with experiments based on a single GPCR expression, our approach provides statistically significant results and indicates that up to 40% of GPCRs can be expressed as inclusion bodies in quantities sufficient for subsequent refolding, solubilization, and purification.

[1]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[2]  K. Lundstrom,et al.  Semliki Forest virus vectors for overexpression of 101 G protein-coupled receptors in mammalian host cells. , 2006, Protein expression and purification.

[3]  S. Rasmussen,et al.  A monoclonal antibody for G protein–coupled receptor crystallography , 2007, Nature Methods.

[4]  A. Plückthun,et al.  Construction and characterization of a kappa opioid receptor devoid of all free cysteines. , 2004, Protein engineering, design & selection : PEDS.

[5]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[6]  R. Grisshammer,et al.  Purification and characterization of the human adenosine A2a receptor functionally expressed in Escherichia coli , 2002 .

[7]  C. Cambillau,et al.  Expression and characterization of the protein Rv1399c from Mycobacterium tuberculosis. A novel carboxyl esterase structurally related to the HSL family. , 2004, European Journal of Biochemistry.

[8]  Joseph Parello,et al.  Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.

[9]  H. Michel,et al.  Heterologous expression and characterization of the recombinant bradykinin B2 receptor using the methylotrophic yeast Pichia pastoris. , 2007, Protein expression and purification.

[10]  F. Pattus,et al.  Dot-blot immunodetection as a versatile and high-throughput assay to evaluate recombinant GPCRs produced in the yeast Pichia pastoris. , 2006, Protein expression and purification.

[11]  G. Rabut,et al.  Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors. , 2003, Protein expression and purification.

[12]  G. Schertler Signal transduction: The rhodopsin story continued , 2008, Nature.

[13]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[14]  J. Banères,et al.  Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1. , 2003, Journal of molecular biology.

[15]  R. Rudolph,et al.  In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor. , 2002, Biophysical chemistry.

[16]  R. Cébe,et al.  Engineering and functional immobilization of opioid receptors. , 2005, Protein engineering, design & selection : PEDS.

[17]  J. Pin,et al.  Asymmetric conformational changes in a GPCR dimer controlled by G‐proteins , 2006, The EMBO journal.

[18]  B. Kobilka,et al.  New G-protein-coupled receptor crystal structures: insights and limitations. , 2008, Trends in pharmacological sciences.

[19]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[20]  J. Banères,et al.  Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1* , 2004, Journal of Biological Chemistry.

[21]  J. Walker,et al.  Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. , 1996, Journal of molecular biology.

[22]  H. Michel,et al.  Enhancing functional production of G protein‐coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen , 2006, Protein science : a publication of the Protein Society.

[23]  H Breer,et al.  Expression of an olfactory receptor in Escherichia coli: purification, reconstitution, and ligand binding. , 1996, Biochemistry.

[24]  A. Desmyter,et al.  Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems , 2007, Journal of Structural and Functional Genomics.

[25]  J. Bockaert,et al.  Molecular Characterization of a Purified 5-HT4 Receptor , 2005, Journal of Biological Chemistry.

[26]  M. Vidal,et al.  GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. , 2000, Methods in enzymology.

[27]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[28]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[29]  Vasilis J. Promponas,et al.  PRED-GPCR: GPCR recognition and family classification server , 2004, Nucleic Acids Res..

[30]  R. Vincentelli,et al.  Automated expression and solubility screening of His-tagged proteins in 96-well format. , 2005, Analytical biochemistry.

[31]  J. Shiloach,et al.  Automated large‐scale purification of a G protein‐coupled receptor for neurotensin , 2004, FEBS letters.

[32]  W. Hendrickson,et al.  Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. , 1995, Structure.

[33]  G. Terstappen,et al.  In silico research in drug discovery. , 2001, Trends in pharmacological sciences.

[34]  Renaud Vincentelli,et al.  Medium-scale structural genomics: strategies for protein expression and crystallization. , 2003, Accounts of chemical research.